Aarti Industries possess world-class expertise in development and manufacture of several basic chemicals, agrochemicals, specialty chemicals, and intermediates for pharmaceuticals and agrochemicals.

A specialised API manufacturing facility, named Aarti Healthcare was launched in the year 2000. It's key business focus is on: 1. Active Pharmaceutical Ingredients 2. Custom Synthesis & Contract Research

API manufacturing division

Our active pharmaceutical ingredients manufacturing facility is USFDA & EUGMP which are accredited with dedicated production blocks for Steroids and Onc​ological APIs.

One of the reasons why we sustain our leadership position is because of backward integration.​ Manufacturing of the key raw materials for Its ​strongest products is the core strength of the API business which ​enables Aarti to sustain its leadership position.

We have some dedicated, world class manufacturing facilities for Xanthine derivatives with a​ Mammoth capacity​ for its flagship product, Caffeine (3600 Mt capacity per annum).

We are also the preferred partner in the regulated markets since we provide Regulatory Documentation & IPR support for global markets (17 CEPs & 26 USDMFs).



Aarti Intermediates and Contract Research division

Aarti Intermediates and Contract Research division has emphasis on tailored process development, scale-up and exclusive manufacturing. These services are provided under strict Intellectual Property Protection guarded by confidentiality agreements with our clients.

The goal is to provide reliable and strong platform to our customers, enabling them to accelerate their NCE & API's development programme, efficiently and cost effectively.

health care

MANUFACTURING UNITS

AARTI INDUSTRIES LIMITED - UNIT I DOMBIVLI
specializes in the manufacture of Active Pharmaceutical Ingredients.

The facility is aligned with R & D of Autoclave , Flow reactors, RBF & other equipment capability of approximately 234 Lit.

The R & D facility has Human Resource strength of 44 dedicated employees.

This unit is Capable of handling the following reactions:

  • Asymmetric Hydrogenation
  • Darzens Glycidic Ester Condensation
  • Butyl Lithium Reaction
  • Hetero Diels Alder Reaction
  • Cyclopropane Chemistry
  • Purine Chemistry
  • Catalytic Hydrogenation
  • Pyrrole Chemistry
  • Nucleoside Chemistry
  • Pyridine Chemistry
  • Suzuki Coupling & Reaction
  • Pyrimidine Chemistry
  • Swern Oxidation
  • Indole Chemistry
  • Sandmeyer Reaction
  • Grignard Reaction

IN recent years the AARTI INDUSTRIES LIMITED - UNIT I has been accredited with the below mentioned certifications from authorities around the globe.
ISO 9001:2008

Custom Synthesis Division, Aarti Industries Limited

  • The site has four manufacturing blocks aligned with more than 75 reactors (SS reactors, GLR reactors, hydrogenetor) with a combined capacity of 329000 liters, engaged in manufacturing of Intermediates require for the manufacture of Active Pharmaceutical Ingredients.
  • The site has the strength of 350 well-trained personnel for ensuring adherence to quality systems and procedures.

This site is capable of handling the following reactions:

  • Hydrogenation
  • Bromination
  • Chlorination
  • Condensation
  • Reduction
  • Oxidation
  • Sulfonation
  • Hydrolysis
  • Esterification
  • Friedel–Craft alkylation, etc.

Capabilities:

  • To carry out hydrogenation up to 10 kg /cm2
  • To carry out reactions at -10°C to 200°C
  • To carry out high vacuum distillations
  • To maintain Zero liquid discharge (liquid effluent is treated and recycled)

The site has been accredited with the following certifications:

Authority Date of Audit
USFDA Approved since June 2010
ISO
  • ISO:9001:
  • Certified since 2011
  • Latest successful inspection in March 2016
OHSAS
  • OHSAS:18001:-Certified since 2011
  • -Latest successful inspection in March 2016

AARTI INDUSTRIES LIMITED - UNIT III
specializes in the manufacture of Xanthine derivatives including Caffeine, Theophylline, Etofylline, and Aminophylline.

The facility is aligned with SS reactors, GLR reactors & PP reactors with an API manufacturing capability of approximately 300 metric tonnes per month.

The facility has Human Resource strength of 136 dedicated employees.

This unit is Capable of handling the following reactions:

  • Nitrosation
  • Hydrogenation
  • Formylation
  • Cyclation
  • Methylation
  • Ethylation

IN recent years the AARTI INDUSTRIES LIMITED - UNIT III has been accredited with the below mentioned certifications from authorities around the globe.
cGMP
ISO 9001:2008
HACCP
HALAL
STAR KOSHER
FSSAI
EIA

AARTI INDUSTRIES LIMITED - UNIT IV
manufacturing Blocks which specialize in the manufacture of General APIs, Steroids and Anticancer APIs

Manufacturing Block No. – 1 : General API
Manufacturing Block No. – 2 : Steroids API (Dedicated)
Manufacturing Block No. – 3 : Anticancer API (Dedicated)
Manufacturing Block No. – 4 : General API

These blocks in the facility are aligned with more than 50 reactors (SS reactors, GLR reactors & PVDF reactors) with a combined capacity of 102,500L.

The facility has Human Resource strength of 345 dedicated employees.

This unit is Capable of handling the following reactions:

  • Hydrogenation
  • Bromination
  • Condensation
  • Reduction
  • Oxidation
  • Methylation
  • Grignard
  • Sulfonation

Capabilities:

  • Reaction volume from 1 Kg output to 500 Kg output
  • Reaction temperature from -30°C to 200°C

AARTI INDUSTRIES LIMITED - UNIT IV has been accredited with the below mentioned certifications from authorities around the globe.
Detailed accreditations & address mentioned on certification by authorities.

Authority Address of Aarti Unit IV
USFDA Approved since June 2010
ISO
  • APPROVED in March 2008
  • APPROVED in September 2011
  • APPROVED in March 2015
EU-GMP
  • APPROVED by Danish Medicines Agency in April 2008
  • APPROVED by Freie und Hansestadt Hamburg May 2012
  • APPROVED by Freie und Hansestadt Hamburg in Aug 2013
  • APPROVED by Freie und Hansestadt, Hamburg in Jan 2015
ISO
  • ISO 9001: 2000 certified since April 2006
  • Latest successful inspection in August 2015
WHO-GMP
  • WHO GMP certified since Oct 2006
  • Latest successful inspection in Dec 2015

AARTI INDUSTRIES LIMITED - UNIT V
specializes in the manufacture of General API

The facility is aligned with SS reactors with a total capacity of 50,500L

The facility has Human Resource strength of 47 dedicated employees.

This unit is Capable of handling Methylation reaction.

Capabilities:

  • Reaction volume from 1 Kg output to 500 Kg output
  • Reaction temperature from -30°C to 200°C

AARTI INDUSTRIES LIMITED - UNIT V has been accredited with the below mentioned certifications from authorities around the globe.

Authority Address of Aarti Unit 5
Mfg License
(KD-769)
Aarti Industries Limited- Unit No. V,
Plot No. L-28/29, MIDC Tarapur, Dist: Thane.Pin-401506
GMP Aarti Industries Limited (732570), L-28, & L-29, MIDC Tarapur Plot
No-L-28 & L-29 MIDC Tarapur- 401506, Tal. Palghar, Dist- Thane-Zone4
ISO 9001: 2008 Aarti Industries Limited- Unit V,
Plot No.L-28/29, Tarapur MIDC Area, Dist. Palghar 401 506
Maharashtra, India.
ISO 22000: 2005 Aarti Industries Limited- Unit V,
Plot No.L-28/29, Tarapur MIDC Area, Dist. Palghar 401 506
Maharashtra, India.
FSSC 22000 Aarti Industries Limited- Unit V,
Plot No.L-28/29, Tarapur MIDC Area, Dist. Palghar 401 506
Maharashtra, India.
EU written Confirmation Aarti Industries Limited- Unit V,
L-28/29,MIDC Tarapur, Dist. Thane-401506.
FSSAI Aarti Industries Limited- Unit No. V, L-28/29,MIDC,Tarapur
Boisar-401506Dist. Thane,Thane (Maharashtra)-401506.
HACCP Aarti Industries Limited- Unit V,
Plot No. L-28/29,MIDC,Tarapur, Tal- Palghar, Dist- Thane,
Pin-401506, Maharashtra, India
HALAL Aarti Industries Limited- Unit V,
Plot No. L-28/29,MIDC,Tarapur, Tal- Palghar, Dist- Thane,
Pin-401506, Maharashtra, India
KOSHER Aarti Industries Limited- Unit V, Boisar, Maharashtra,India.
SMETA 4-pillar (Sedex) Aarti Industries Limited- Unit V, Plot No.: L-28/29, Tarapur MIDC.
Tal- Palghar, Dist.-Thane. Maharashtra, India. Pin code – 401506.

AARTI INDUSTRIES LIMITED - UNIT I, Phase-II
specializes in the manufacture of Active Pharmaceutical Ingredients.

The facility is aligned with SS reactors, GLR reactors, hydrogenator & PP reactors with an API manufacturing capability of reactor is approximately 31,510L

The facility of Manufacturing has Human Resource strength of 171 dedicated employees.

This unit is Capable of handling the following reactions:

  • Asymmetric Hydrogenation
  • Darzens Glycidic Ester Condensation
  • Butyl Lithium Reaction
  • Hetero Diels Alder Reaction
  • Cyclopropane Chemistry
  • Purine Chemistry
  • Catalytic Hydrogenation
  • Pyrrole Chemistry
  • Nucleoside Chemistry
  • Pyridine Chemistry
  • Suzuki Coupling & Reaction
  • Pyrimidine Chemistry
  • Swern Oxidation
  • Indole Chemistry
  • Sandmeyer Reaction
  • Grignard Reaction

IN recent years the AARTI INDUSTRIES LIMITED - UNIT I has been accredited with the below mentioned certifications from authorities around the globe.
cGMP
ISO 9001:2008
WHO-GMP

OUR PRODUCTS

Products under the Healthcare division are well recognised in the world market. To march ahead with forward integration, Aarti has recently established a Custom Synthesis division. Presently, pharmaceutical intermediates are being manufactured in the Custom Synthesis plant in order to cater the needs of various Indian and International customers.

The products are divided into 3 verticals:

  1. API
  2. Intermediates
  3. Xanthine derivatives
  4. KNOW MORE

OUR SERVICES

The contract Research and Manufacturing Services (CRAMS) is our fastest growing business segment in healthcare division of Aarti Industries.

Aarti CRAMS is one of the leading cost-competitive and quality manufacturing hubs for many global players including big pharma companies. CRAMS basically consists of the following two activities:

  1. Contract research organizations (CROs) and
  2. Contract manufacturing organizations (CMOs)
KNOW MORE